PharmScript LLC, Somerset, NJ

Is PharmScript LLC registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does PharmScript LLC hold a New Jersey pharmacy license?

State board of pharmacy records for New Jersey are not checked: the Division of Consumer Affairs website, which publishes pharmacy permit records and board actions, answers automated requests with a bot challenge, and the state’s public license lookup lists individual licensees but not pharmacy permits; this index does not work around blocks. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054020924 for PHARMSCRIPT LLC, SOMERSET, NJ, status ACTIVE, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002168 for PHARMSCRIPT LLC, SOMERSET, NJ, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0001048 for PharmScript, LLC, SOMERSET, NJ, status Active, as of Nov 10, 2026. The Michigan Department of Licensing and Regulatory Affairs also lists nonresident license 5301011412 for PharmScript LLC, Somerset, NJ, status Active, as of Nov 10, 2026.

Has PharmScript LLC had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Jul 29, 2019), 1 state referral letter (Jul 29, 2019) and 1 FMD-145 letter (Jul 29, 2019) for PharmScript LLC. State board of pharmacy records for New Jersey are not checked: the Division of Consumer Affairs website, which publishes pharmacy permit records and board actions, answers automated requests with a bot challenge, and the state’s public license lookup lists individual licensees but not pharmacy permits; this index does not work around blocks. The New York State Education Department’s list of Board of Regents disciplinary actions against pharmacy establishments also lists “Application for consent order granted; Penalty agreed upon: Censure and reprimand, $2,000 fine” dated Oct 7, 2025, case Cal. No. 34760 on nonresident registration 029382. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
PharmScript LLC
Location
Somerset, NJ
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jul 29, 2019
FDA Data Dashboard inspections
1 inspection: 1 OAI; 2 published Form 483s
Form 483 text on this page
1 Form 483, 4 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as PharmScript LLC, a 503A facility, with 3 dated actions.

Document
Jul 29, 2019State referral letterReferral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019FDA copy (archived)
Jul 29, 2019FMD-145 letterFMD-145 Letter Issued 07/29/2019fda.gov
Jul 29, 2019Warning letter close-outWarning Letter Close Out Issued 07/29/2019Not linked by FDA

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists PharmScript, LLC, Somerset, NJ (FEI number 3012837733), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Oct 24, 2016Official Action Indicated (OAI)Drug Quality Assurance (Drugs)3012837733993187

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 4 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Jul 30, 2018 to Aug 7, 2018: 4 observations

Firm on the cover
P harmScript, LL C, 1 50 P ierce St ., Somerset, N J 08873 -4185
FEI number
3012837733
Establishment type on the cover
Producer of sterile and non- sterile d rug p roducts
FDA district office on the cover
ars ippany, NJ 07054
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.

Observation 1

You produced beta-lactam drugs without providing adequate containment, segregation and cleaning of work surfaces to prevent cross-contamination.

Specifically, your firm is processing beta-lactams in the same ISO 5 hood as non-beta-lactam sterile injectable IV products, without adequate cleaning of work surfaces.

Additionally, on 8/2/2018 we observed a sterile beta-lactam drug product, Meropenem IV solution, 2 grams/100 ml (RX <Redacted B4>), being processed, in the "left" ISO 5 hood. During that processing, a small unit of the beta-lactam during your product sprayed on the interior back <Redacted B4> side of the ISO 5 hood, when the This surface supplies the flow of HEP A filtered air across the critical ISO 5 area. That surface ofthe ISO 5 hood\Vas not cleaned and sanitized before a non-beta-lactam drug product, Methylpredisone IV solution 40 mg /100 ml 0.9% NaCl (RX <Redacted B4>), was processed.

Observation 2

The use of sporicidal agents in the ISO 5 classified aseptic processing area was inadequate.

Observation 3

Personnel engaged in aseptic processing were obse1ved with exposed hands, exposed wrists and exposed hair.

Specifically, A Your cleanroom operators exposed their bare hands and wrists inside the ISO 5 area, as part of your gowning procedure for donning sterile gloves. Sterile injectable drug products were then aseptically processed in this area.

B. Your cleanroom operators exposed their facial skin and the hair around their eyes and forehead to the ISO 5 area. This occurred while aseptically processing sterile injectable drug products and during sanitization of the ISO 5 hood between drug products. On 7/30/2018, we observed on two occasions that your cleanroom operators processed sterile injectable drug products, while not wearing the sterile gown hood over their hairnet.

Observation 4

Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area with gloved hands and then engaged in aseptic processing without changing or sanitizing gloves.

Specifically, we observed some poor aseptic practices, such as:

A On 7/31/2018, your cleanroom pharmacy technician used a bottle of that fell from the cart to the floor of the ISO 7 buffer room three (3) time <Redacted B4> without wiping the bottle itself, which then became a potential source of contamination to the technician's gloves and the other surfaces upon which that bottle was rested.

B. On 7/31/2018, your cleanroom pharmacy technician touched the base of a chair in the ISO 7 buffer room immediately before processing in the ISO 5 area without sanitizing his gloves.

C. On 7/31/2018 and 8/2/2018, individually packaged < Redacted B4> wipes, stored immediately beneath the ISO 5 processing hood in the ISO 7 area, were not sanitized prior to them being introduced into the ISO 5 area.

D. On 8/2/2018 a cleanroom operator allowed the sleeves of the gown to touch the floor of the ISO 8 ante room during the gowning process. ...

Read the full 483 (PDF on fda.gov)

Linked 483s whose text is not shown

State board of pharmacy records

State board of pharmacy records for New Jersey are not checked: the Division of Consumer Affairs website, which publishes pharmacy permit records and board actions, answers automated requests with a bot challenge, and the state’s public license lookup lists individual licensees but not pharmacy permits; this index does not work around blocks.

Nonresident licenses and board actions in other states

These boards list a nonresident license or a board action whose record names this pharmacy’s own name, city and state.

New York State Education Department, board actions read Nov 8, 2026 (New York).

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054020924LICENSED PHARMACYPHARMSCRIPT LLCSOMERSET, NJACTIVE

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0002168NONRESIDENT PHARMACYPHARMSCRIPT LLCSOMERSET, NJACTIVE (CURRENT)

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0001048Non Resident PharmacyPharmScript, LLCSOMERSET, NJActive

Michigan Department of Licensing and Regulatory Affairs, file dated Nov 10, 2026 (Michigan).

LicenseType as the board gives itName on the board recordLocationStatus
5301011412PharmacyPharmScript LLCSomerset, NJActive

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.